While Elizabeth Holmes, the founder of failed blood-testing company Theranos, was convicted of fraud and conspiracy to commit fraud earlier this year, her then partner and Theranos chief operating officer, Ramesh Balwani, now awaits the verdict of his fraud trial.
The media has covered the trials in detail, but those who still have questions about Theranos and how the truth got out will have a chance to get answers on July 26 at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, where Theranos whistleblowers Erika Cheung and Tyler Schultz plan to speak about their experience.
A complete reversal from Holmes’s own appearance at the 2016 AACC Annual Scientific Meeting in a failed attempt to dispel growing suspicion about Theranos’s “innovative” blood testing technology, Cheung and Schultz will discuss the challenges they faced around exposing Theranos’s fraud, as well as their efforts to protect patients from bogus test results while they were still working at the company. The discussion will also touch on the overall ethical obligations of clinical labs and the essential role of clinical lab professionals of protecting patients.
The discussion with Cheung and Schultz will be moderated by Dr. Stephen R. Master, AACC president, who served as an expert witness in Holmes’s trial. “It is a great honor to be able to feature Erika Cheung and Tyler Shultz at the AACC Annual Scientific Meeting,” said Master in a recent AACC press release. “They exemplify the commitment that all laboratory medicine professionals have to providing high quality test results that lead to effective patient care, and they are an inspiration to the community at large. All of us at AACC are looking forward to hearing their insights into the ethics of laboratory testing.”
To learn more about the upcoming presentation by Cheung and Schultz, read the full article at G2 Intelligence’s partner brand, Today’s Clinical Lab.